及时性和指导方针一致性治疗的差异与公共和私人肺癌患者的过度死亡率有关
Jonathan Pham1, Tiffany Lin1, Eldho Paul2
1Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
Asia-Pacific journal of clinical oncology
|August 8, 2025
概括
与私立医院相比,患有肺癌的公立医院患者面临严重的治疗延迟和较低的生存率. 这凸显了澳大利亚癌症护理中的严重健康不平等,需要紧急关注和改进.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 以前的研究表明,在肺癌治疗方面存在健康差异.
- 公立和私立医院之间的医疗保健提供差异可能会导致这些不平等.
研究的目的:
- 评估医院类型 (公共与私人) 与接受指导方针一致治疗 (GCT) 之间的关联.
- 评估医院类型对肺癌患者生存结果的影响.
主要方法:
- 来自维多利亚州肺癌登记处的11,396名患者的回顾性研究 (2011年4月-2022年3月).
- 对多个患者和疾病特征的倾向性得分进行调整.
- 公立和私立医院患者之间的治疗及时性,GCT接收和存活率的比较.
主要成果:
- 公共医院的患者经历了显著更长的治疗延迟 (中位数为48天而不是29天).
- 私立医院患者在大多数非小细胞肺癌 (NSCLC) 阶段更有可能接受GCT.
- 私立医院患者在NSCLCI,II和IV阶段的生存率有所改善,在III阶段几乎显著的好处.
结论:
- 公共医院的患者面临大量的延迟,较低的GCT率,以及在肺癌治疗中较差的生存率.
- 在澳大利亚肺癌护理中存在重大的健康不平等和差异.
- 在澳大利亚公立医院内评估和增强肺癌治疗方案至关重要.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.6K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
相关概念视频
01:25Statistical Methods for Analyzing Epidemiological Data
536
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
536
01:21Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455
01:17Other Pulmonary Disorders
911
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
911
01:12Hazard Ratio
247
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
247